Soldierer M, Bister A, Haist C, Thivakaran A, Cengiz S, Sendker S, et al. Genetic Engineering and Enrichment of Human NK Cells for CAR-Enhanced Immunotherapy of Hematological Malignancies. Front Immunol. 2022;13:847008 pubmed publisher

Palamarchuk A, Alekseeva N, Streltsova M, Ustiuzhanina M, Kobyzeva P, Kust S, et al. Increased Susceptibility of the CD57- NK Cells Expressing KIR2DL2/3 and NKG2C to iCasp9 Gene Retroviral Transduction and the Relationships with Proliferative Potential, Activation Degree, and Death Induction Response. Int J Mol Sci. 2021;22: pubmed publisher

Kräter M, Abuhattum S, Soteriou D, Jacobi A, Krüger T, Guck J, et al. AIDeveloper: Deep Learning Image Classification in Life Science and Beyond. Adv Sci (Weinh). 2021;8:e2003743 pubmed publisher

Gong Y, Klein Wolterink R, Janssen I, Groot A, Bos G, Germeraad W. Rosuvastatin Enhances VSV-G Lentiviral Transduction of NK Cells via Upregulation of the Low-Density Lipoprotein Receptor. Mol Ther Methods Clin Dev. 2020;17:634-646 pubmed publisher

Dumont A, de Rosny C, Kieu T, Perrey S, Berger H, Fluckiger A, et al. Docosahexaenoic acid inhibits both NLRP3 inflammasome assembly and JNK-mediated mature IL-1β secretion in 5-fluorouracil-treated MDSC: implication in cancer treatment. Cell Death Dis. 2019;10:485 pubmed publisher

Andre P, Denis C, Soulas C, Bourbon Caillet C, Lopez J, Arnoux T, et al. Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells. Cell. 2018;175:1731-1743.e13 pubmed publisher

Holder K, Lajoie J, Grant M. Natural Killer Cells Adapt to Cytomegalovirus Along a Functionally Static Phenotypic Spectrum in Human Immunodeficiency Virus Infection. Front Immunol. 2018;9:2494 pubmed publisher

Tomalka A, Resto Garay I, Campbell K, Popkin D. In vitro Evidence That Combination Therapy With CD16-Bearing NK-92 Cells and FDA-Approved Alefacept Can Selectively Target the Latent HIV Reservoir in CD4+ CD2hi Memory T Cells. Front Immunol. 2018;9:2552 pubmed publisher

Bonacini M, Soriano A, Zerbini A, Calò E, Cimino L, Muratore F, et al. Higher Frequencies of Lymphocytes Expressing the Natural Killer Group 2D Receptor in Patients With Behçet Disease. Front Immunol. 2018;9:2157 pubmed publisher

Boin F, Giardino Torchia M, Borrello I, Noonan K, Neil M, Soloski M, et al. Flow cytometric discrimination of seven lineage markers by using two fluorochromes. PLoS ONE. 2017;12:e0188916 pubmed publisher

Delso Vallejo M, Kollet J, Koehl U, Huppert V. Influence of Irradiated Peripheral Blood Mononuclear Cells on Both Ex Vivo Proliferation of Human Natural Killer Cells and Change in Cellular Property. Front Immunol. 2017;8:854 pubmed publisher

Dong P, Wen X, Liu J, Yan C, Yuan J, Luo L, et al. Simultaneous detection of decidual Th1/Th2 and NK1/NK2 immunophenotyping in unknown recurrent miscarriage using 8-color flow cytometry with FSC/Vt extended strategy. Biosci Rep. 2017;37: pubmed publisher

Veluchamy J, Lopez Lastra S, Spanholtz J, Bohme F, Kok N, Heideman D, et al. In Vivo Efficacy of Umbilical Cord Blood Stem Cell-Derived NK Cells in the Treatment of Metastatic Colorectal Cancer. Front Immunol. 2017;8:87 pubmed publisher

Canté Barrett K, Mendes R, Li Y, Vroegindeweij E, Pike Overzet K, Wabeke T, et al. Loss of CD44dim Expression from Early Progenitor Cells Marks T-Cell Lineage Commitment in the Human Thymus. Front Immunol. 2017;8:32 pubmed publisher

Petty R, McCarthy N, Le Dieu R, Kerr J. MicroRNAs hsa-miR-99b, hsa-miR-330, hsa-miR-126 and hsa-miR-30c: Potential Diagnostic Biomarkers in Natural Killer (NK) Cells of Patients with Chronic Fatigue Syndrome (CFS)/ Myalgic Encephalomyelitis (ME). PLoS ONE. 2016;11:e0150904 pubmed publisher